Royalty Pharma Plc undefined said Monday it agreed to pay up to $1.125 billion for drug royalties owned by Ionis Pharmaceuticals Inc. undefined. The...
Royalty Pharma Plc said Monday it agreed to pay up to $1.125 billion for drug royalties owned by Ionis Pharmaceuticals Inc. . The royalties include Ionis' interests in Biogen's Spinraza medicine and Novartis' pelacarsen. Shares of Royalty Pharma rose 1.9% in premarket trades while Ionis rose 2.6%.
... Royalty Pharma Plc RPRX said Monday it agreed to pay up to $1.125 billion for drug royalties owned by Ionis Pharmaceuticals Inc. IONS . The royalties include Ionis' interests in Biogen's BIIB Spinraza medicine and Novartis' NVS pelacarsen. Shares of Royalty Pharma rose 1.9% in premarket trades while Ionis rose 2.6%.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 bln dealAstraZeneca said on Monday it will buy U.S.-based clinical-stage biopharmaceutical firm CinCor Pharma Inc in a deal valued at about $1.8 billion to strengthen its pipeline of heart and kidney drugs.
Lire la suite »
Breakingviews - AstraZeneca’s new deal is smarter than it looksOn the face of it, Pascal Soriot’s new deal ought to raise his shareholders’ blood pressure. The boss of $221 billion pharma giant AstraZeneca has agreed to buy CinCor Pharma for up to $1.8 billion. Yet paying $26 in cash per CinCor share and an extra $10 per share if a key drug is submitted for regulatory approval represents a 206% bump to CinCor’s closing share price on Friday. That’s around four times the average premium on recent industry deals.
Lire la suite »
AstraZeneca PLC Will Buy CinCor for Cardiorenal AssetBy Joe Hoppe AstraZeneca PLC said Monday that it has agreed to buy CinCor Pharma, Inc., acquiring global rights to the latter's baxdrostat cardiorenal drug...
Lire la suite »
AstraZeneca boosts heart, kidney business with $1.8 bln CinCor dealAstraZeneca said on Monday it had struck a deal to buy U.S.-based drug developer CinCor Pharma Inc for up to $1.8 billion to increase its stock of heart and kidney drugs.
Lire la suite »
Report: Saints, Michael Thomas Agree to Restructured ContractThe Saints and wide receiver Michael Thomas agreed to a restructured contract that creates a potential deadline for the team to decide whether to bring him back next year
Lire la suite »
Indonesia and Malaysia agree to fight 'discrimination' against palm oilIndonesia and Malaysia, the world's biggest producers of palm oil, agreed on Monday to work together to fight 'discrimination' against the commodity after a meeting between leaders from the countries.
Lire la suite »